 Phase 0a clinical trial of complement C0 inhibitor AMY-000 in adults with periodontal inflammation BACKGROUND. Gingivitis and periodontitis are prevalent inflammatory diseases of the periodontal tissues. Current treatments are often ineffective or do not prevent disease recurrence. Uncontrolled